相关实验视频

Updated: May 25, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

基于抗体的免疫刺激药物的进展:推动癌症治疗的创新

Ren-Jie Zhao¹, Xing-Xing Fan¹

¹Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau SAR 999078, China.

International journal of molecular sciences

|February 26, 2025

概括

基于抗体的免疫刺激药物 (ABI) 正在推进癌症免疫疗法. 这些药物,包括免疫刺激抗体合物 (ISAC) 和双特异性抗体 (BsAbs),在克服免疫抑制和改善患者结果方面表现有前途.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

基于抗体的免疫刺激药物 (ABI) 为癌症免疫疗法提供了一种新的方法.
这些药物旨在修改瘤微环境并抵消免疫抑制.

研究的目的:

审查ABI的最新进展,重点关注免疫刺激抗体合物 (ISAC),双特异性抗体 (BsAbs) 和检查点阻塞增强剂.
讨论与这些疗法相关的作用机制,临床进展和挑战.
探索人工智能 (AI) 在优化 ABI 开发中的作用.

主要方法:

对临床前发现和ABI临床进展的审查.
对ISAC和BsAbs. 的行动机制的分析.
评估AI在药物设计中的应用,并为ABI确定目标.

主要成果:

ISACs通过重编程与瘤相关的巨细胞和增强T细胞激活来证明其有效性.
BsAbs有效地将免疫细胞重定向到瘤,导致显著的瘤回归.
人工智能正在加速ABI开发,使个性化治疗策略成为可能.

结论:

尽管存在诸如免疫抵抗和非目标效应等挑战,但ABI具有显著的治疗潜力.
未来的研究应该专注于下一代多功能抗体,人工智能驱动的创新和组合疗法.
优化ABI可以改善耐火或耐药癌症患者的治疗结果.

关键词:

基于抗体的免疫刺激药物.人工智能的人工智能是人工智能.两种特异性的抗体.免疫刺激性抗体结合剂的结合物

更多相关视频

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...